Related Experiment Videos
Sublingual nitroglycerin: improving patient compliance with a demonstration dose
1Department of Family Practice, Kaiser-Permanente, San Diego, CA 92120.
The Journal of the American Board of Family Practice
|October 1, 1988
Summary
Physician-supervised administration of the first dose of sublingual nitroglycerin significantly improves patient compliance. This approach ensures patients use their angina medication as prescribed, enhancing treatment effectiveness.
Area of Science:
- Cardiology
- Pharmacology
- Patient Adherence Research
Background:
- Sublingual nitroglycerin is a critical medication for angina pectoris management.
- Patient compliance with new prescriptions can be a significant challenge in chronic disease management.
Purpose of the Study:
- To evaluate the impact of physician-supervised first-dose administration on sublingual nitroglycerin compliance.
- To assess patient adherence to sublingual nitroglycerin prescriptions.
Main Methods:
- A randomized, prospective study involving 44 patients diagnosed with angina pectoris.
- Physicians administered the first dose of sublingual nitroglycerin to a study group; a control group did not receive a supervised first dose.
- Patient compliance was assessed based on self-reported use before the second visit.
Main Results:
- Patients receiving a supervised first dose were significantly more likely to have used sublingual nitroglycerin (75%) compared to the control group (44%).
- No significant difference was observed in patients having the medication available at the second visit.
- Six patients experienced adverse effects from the first dose, including one instance of syncope.
Conclusions:
- Physician supervision of the initial dose of sublingual nitroglycerin enhances patient compliance.
- This intervention can improve the effective utilization of nitroglycerin for angina patients.
- While generally safe, potential side effects from the first dose should be monitored.